M. Scaramozza - Biogen, Cambridge, MA USA

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 16 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety and Efficacy of Diroximel Fumarate in Older Patients with Multiple Sclerosis from the Phase 3 EVOLVE-MS-1 Study

S. Faissner,L. Goldstick,C. Ford,F. Branco,H. Chen, S. Levin,M. Scaramozza, S. Shankar,M. Perez

EUROPEAN JOURNAL OF NEUROLOGY (2023): 422-423

引用0浏览0引用

Efficacy and Safety Outcomes with Diroximel Fumarate in Patients with a History of Prior Sphingosine1-Phosphate Receptor Modulators or High-Efficacy Therapies as their Most Recent Therapy: Results from the Phase 3 EVOLVE-MS-1 Study

B. A. Singer,S. Wray, S. M. England,F. Branco,M. Scaramozza, S. Levin,H. Chen, I. Yun,F. Then Bergh

MULTIPLE SCLEROSIS JOURNAL (2023): 53-54

引用0浏览0引用

Performance differences observed with fixed versus dynamic reference keys within Konectom smartphone-based cognitive processing speed

L. Zajac, P. A. Chiesa,M. Deloire,M. Scaramozza, Z. Sun, M. Tang, A. Juraver,E. Bartholome,A. Saubusse, J. Charre Morin, N. Campbell,J. van Beek,T. Guymard,A. Scotland,B. Brochet,S. Belachew,A. Ruet

MULTIPLE SCLEROSIS JOURNAL（2022）

引用0浏览0引用

Moving beyond the number of correct responses as an outcome measure in symbol-digit substitution testing using Konectom^? smartphone-based cognitive processing speed test

M. Scaramozza, P. A. Chiesa,M. Deloire,L. Zajac, Z. Sun, M. Tang A. Juraver,E. Bartholome,A. Saubusse, J. Charre Morin, N. Campbell,J. van Beek,T. Guymard,A. Scotland,B. Brochet,S. Belachew,A. Ruet

MULTIPLE SCLEROSIS JOURNAL（2022）

引用0浏览0引用

Konectom? Cognitive Processing Speed Testing and the Influence of Reaction Time

M. Scaramozza, P. A. Chiesa,A. Scotland, Z. Sun,R. Rajbhandari, A. Juraver,B. Brochet,M. Deloire,A. Saubusse,J. Charre-Morin,C. Dulong, C. Shen, L. Carment,T. Guymard,J. Van Beek, M. Ruiz,S. Belachew,A. Ruet

MULTIPLE SCLEROSIS JOURNAL（2022）

引用0浏览0引用

Flushing and flushing-related adverse events with diroximel fumarate in patients with relapsing-remitting multiple sclerosis: results from the Phase 3 EVOLVE-MS-2 Study

B. A. Singer,S. Faissner,J. Lyons,M. Scaramozza,C. Woodward,H. Chen,F. Branco, R. Vosoughi

MULTIPLE SCLEROSIS JOURNAL（2021）

引用0浏览0引用

Tolerability Of Diroximel Fumarate In Relapsing-Remitting Multiple Sclerosis Patients With Gastrointestinal Comorbidities At Baseline

B. A. Singer,S. Wray,T. Ziemssen,A. Wundes,E. Jasinska,H. Chen,J. B. Lewin,J. Lyons,J. Messer,M. Scaramozza,R. T. Naismith

MULTIPLE SCLEROSIS JOURNAL（2021）

引用0浏览0引用

Pharmacokinetic And Pharmacodynamic Analysis Of Biib091, A Bruton'S Tyrosine Kinase Inhibitor (Btki), In Healthy Volunteers

M. Arefayene,Y. Zhao,M. Scaramozza,B. Hopkins, E. Bame,N. Franchimont,H. Naik

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021): S53-S53

引用0浏览0引用

CONNECT: an open-label, active-controlled dimethyl fumarate study in pediatric patients with relapsing-remitting multiple sclerosis

A. -H. Maghzi,S. Levin.,R. Alroughani,K. Deiva, C. Pozzili,J. Lyons,O. Mokliatchouk, J. Pultz, F. N'Dure,S. Liu, R. Badwan,F. Branco,N. Franchimont,J. Hanna,M. Scaramozza,P. Vermersch

MULTIPLE SCLEROSIS JOURNAL（2021）

引用0浏览0引用

Comparing the impact of dose titration on gastrointestinal tolerability: diroximel fumarate versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis

R. T. Naismith, R. Badwan,H. Chen,J. Lyons, C. Miller,M. Scaramozza,S. L. Shankar, A. Antezana

MULTIPLE SCLEROSIS JOURNAL（2021）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn